We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+48.16%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$28.7B
AUM Growth
+$9.02B
Cap. Flow
+$410M
Cap. Flow %
1.43%
Top 10 Hldgs %
40.88%
Holding
1,054
New
51
Increased
542
Reduced
395
Closed
49

Top Buys

Rank Stock Value
1
EQX icon
Equinox Gold
EQX
+$133M
2
B
Barrick Mining
B
+$122M
3
FNV icon
Franco-Nevada
FNV
+$94.4M
4
NEM icon
Newmont
NEM
+$93.9M
5
BA icon
Boeing
BA
+$64.9M

Sector Composition

Rank Sector Weight
1 Materials 59.42%
2 Technology 12.22%
3 Healthcare 5.75%
4 Financials 3.68%
5 Energy 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COR icon
226
Cencora
COR
$60.6B
$12.8M 0.04%
127,014
+14,573
+13% +$1.34M
BND icon
227
Vanguard Total Bond Market
BND
$157B
$12.6M 0.04%
143,052
+31,353
+28% +$2.74M
AGG icon
228
iShares Core US Aggregate Bond ETF
AGG
$137B
$12.6M 0.04%
106,883
+23,473
+28% +$2.75M
WPX
229
DELISTED
WPX Energy, Inc.
WPX
$12.5M 0.04%
1,964,204
-20,632
-1% -$116K
HLX icon
230
Helix Energy Solutions
HLX
$1.4B
$12.3M 0.04%
3,549,525
-189,363
-5% -$512K
NEA icon
231
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.37B
$12.2M 0.04%
879,013
+80,813
+10% +$1.09M
NAD icon
232
Nuveen Quality Municipal Income Fund
NAD
$2.74B
$12.1M 0.04%
864,634
+79,284
+10% +$1.08M
NVG icon
233
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$12.1M 0.04%
789,399
+52,461
+7% +$770K
TJX icon
234
TJX Companies
TJX
$174B
$11.9M 0.04%
236,146
+4,448
+2% +$223K
NBIX icon
235
Neurocrine Biosciences
NBIX
$16.8B
$11.8M 0.04%
97,103
+24,354
+33% +$2.69M
NVS icon
236
Novartis
NVS
$297B
$11.7M 0.04%
134,054
+20,817
+18% +$1.8M
SNY icon
237
Sanofi
SNY
$103B
$11.7M 0.04%
228,885
+41,989
+22% +$2.04M
AZN icon
238
AstraZeneca
AZN
$263B
$11.6M 0.04%
109,962
+5,641
+5% +$583K
GSK icon
239
GSK
GSK
$104B
$11.3M 0.04%
222,527
+35,897
+19% +$1.84M
AMT icon
240
American Tower
AMT
$80.8B
$11.1M 0.04%
43,061
-452
-1% -$112K
CNH
241
CNH Industrial
CNH
$12.7B
$11.1M 0.04%
1,812,670
-150,388
-8% -$832K
GH icon
242
Guardant Health
GH
$21.7B
$11.1M 0.04%
136,474
+46,031
+51% +$3.71M
ORCL icon
243
Oracle
ORCL
$374B
$11.1M 0.04%
199,932
-917
-0.5% -$48.6K
TEVA icon
244
Teva Pharmaceuticals
TEVA
$40.8B
$10.9M 0.04%
881,084
-48,010
-5% -$543K
LOW icon
245
Lowe's Companies
LOW
$117B
$10.8M 0.04%
79,592
-5,814
-7% -$664K
MAIN icon
246
Main Street Capital
MAIN
$5.06B
$10.7M 0.04%
344,512
-23,334
-6% -$658K
DTP
247
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$10.6M 0.04%
250,802
-13,013
-5% -$538K
GSV
248
DELISTED
Gold Standard Ventures Corp.
GSV
$10.6M 0.04%
13,045,842
-218,850
-2% -$144K
BXMT icon
249
Blackstone Mortgage Trust
BXMT
$2.45B
$10.6M 0.04%
438,181
+163,072
+59% +$3.75M
NVO
250
Novo Nordisk
NVO
$208B
$10.4M 0.04%
319,022
-2,320
-0.7% -$74K

Similar funds

VanEck Associates's Q2 2020 Portfolio in Review

As of Q2 2020, VanEck Associates held 1,054 positions worth $28.7B, up 46% from $19.7B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

VanEck Associates's Q2 2020 filing shows 51 new, 542 increased, 395 reduced and 49 closed positions. Its largest new stake was DRDGold: 4,905,868 shares worth $77.5M. The largest sale was Universal Health Realty Income Trust, an estimated $103M.

By sector, the portfolio is most concentrated in Materials at 59% of assets, up from 55% a quarter earlier, followed by Technology and Healthcare.

  • VanEck Associates's largest Q2 2020 buy was DRDGold: 4,905,868 shares worth $77.5M.
  • VanEck Associates added most to Equinox Gold in Q2 2020, an estimated $133M increase.
  • VanEck Associates's biggest Q2 2020 reduction was Universal Health Realty Income Trust, cutting an estimated $103M.
  • VanEck Associates fully exited Raytheon Company in Q2 2020, selling an estimated $32.3M.
  • VanEck Associates's ten largest holdings make up 41% of its $28.7B portfolio in Q2 2020.
  • VanEck Associates opened 51 new positions and closed 49 in Q2 2020.
  • VanEck Associates's portfolio value rose 46% quarter-over-quarter to $28.7B.

Based on VanEck Associates's 13F filing for Q2 2020, filed 10 Aug 2020.